Rama Phosphates Limited
Rama Phosphates Limited Fundamental Analysis
Rama Phosphates Limited (RAMAPHO.NS) shows moderate financial fundamentals with a PE ratio of 8.57, profit margin of 6.01%, and ROE of 13.94%. The company generates $8.8B in annual revenue with strong year-over-year growth of 18.80%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 64.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze RAMAPHO.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakRAMAPHO.NS struggles to generate sufficient returns from assets.
Valuation Score
ExcellentRAMAPHO.NS trades at attractive valuation levels.
Growth Score
ModerateRAMAPHO.NS shows steady but slowing expansion.
Financial Health Score
ExcellentRAMAPHO.NS maintains a strong and stable balance sheet.
Profitability Score
WeakRAMAPHO.NS struggles to sustain strong margins.
Key Financial Metrics
Is RAMAPHO.NS Expensive or Cheap?
P/E Ratio
RAMAPHO.NS trades at 8.57 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, RAMAPHO.NS's PEG of 0.35 indicates potential undervaluation.
Price to Book
The market values Rama Phosphates Limited at 1.12 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 3.76 times EBITDA. This is generally considered low.
How Well Does RAMAPHO.NS Make Money?
Net Profit Margin
For every $100 in sales, Rama Phosphates Limited keeps $6.01 as profit after all expenses.
Operating Margin
Core operations generate 15.40 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $13.94 in profit for every $100 of shareholder equity.
ROA
Rama Phosphates Limited generates $8.16 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Rama Phosphates Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Rama Phosphates Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
RAMAPHO.NS converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
8.57
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.35
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.12
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.52
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.26
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.009
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.14
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.32
vs 25 benchmark
How RAMAPHO.NS Stacks Against Its Sector Peers
| Metric | RAMAPHO.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 8.57 | 27.18 | Better (Cheaper) |
| ROE | 13.94% | 860.00% | Weak |
| Net Margin | 6.01% | -121084.00% (disorted) | Weak |
| Debt/Equity | 0.26 | 0.41 | Strong (Low Leverage) |
| Current Ratio | 2.01 | 4.81 | Strong Liquidity |
| ROA | 8.16% | -7173.00% (disorted) | Weak |
RAMAPHO.NS outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Rama Phosphates Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
50.63%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
-22.79%
Industry Style: Cyclical, Commodity, Value
DecliningFCF CAGR
52.85%
Industry Style: Cyclical, Commodity, Value
High Growth